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1.  Introduction
There are two common approaches to isolating
vascular smooth muscle cells. The first involves
explanting vascular tissue and then allowing time
for smooth muscle cells to migrate out from the
explanted tissue fragments [4]. Using the explant
technique, we were able to obtain only 750–1500
cells per murine aorta after two weeks in culture. The
explant protocols are therefore generally unsuitable
for isolating and characterizing smooth muscle cells
from limiting amounts of tissue. The second common
approach to isolating vascular smooth cells involves
limited enzymatic digestion of vascular tissue
followed by plating of the dispersed smooth muscle
cells [1, 3]. Using two published versions of proto-
cols that utilize enzymatic digestion, we were unable
to isolate any smooth muscle cells at all, despite
multiple attempts. We present a protocol utilizing
enzymatic digestion that is more detailed than any
protocol we were able to find in the literature, and
is different in critical respects from those protocols.
For example, we found that the specific enzyme
preparation used is critically important, and we
specify the optimal preparation, whereas other pub-
lished protocols do not. In addition, we recommend
digestion times that in our hands are far superior to
the digestion times used in previously published pro-
tocols. Our technique allows the isolation of rela-
tively large numbers of cells (at least 6000 cells per
murine aorta after 7–10 days in culture) in a pre-
dictable manner. We have optimized this technique
for use with a single murine aorta, thus allowing the
relatively rapid characterization of vascular smooth
muscle cells from a particular mouse line when the
number of available animals is limited. We therefore
expect this technique to be particularly useful in the
initial evaluation of genetically modified animals.
2.  Materials
I. Solutions
– Sodium pentobarbital: 1 gm/ml (catalog
#WAB10500, The Butler Company).1
– Phosphate buffered saline: (catalog #10010-023,
Life Technologies).2
– Fungizone solution: 10 µl of 0.25 mg/ml
Fungizone (catalog #15290018, Life Tech-
nologies)2 in 10 ml Dulbecco’s Modified Eagle
Medium (DMEM) (catalog #12430-054, Life
Technologies).2 Filter sterilize. Store at 4 °C, for
no more than three weeks. 
– Culture medium: DMEM with 10% fetal
bovine serum (FBS) (catalog #16000036, Life
Technologies),2 1% penicillin/Streptomycin
(catalog #15140-122, Life Technologies),2 1%
glutamine (catalog #17-605E, BioWhittaker).3
Filter sterilize. Store at 4 °C, for no more than four
weeks.
– Enzyme solution (for several aortas): 7.5 mg
collagenase (type II, product code LS004174,
Worthington Biochemical Corporation)4 in 5.5 ml
culture medium. Filter sterilize using 0.22 micron
low protein binding filter. Prepare fresh for each
isolation procedure.
– 70% Ethanol: 70% (v/v) 200 proof ethanol
(catalog #111000200DC05, Pharmco),8 30% (v/v)
deionized water.
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Abstract. The vascular smooth muscle cell plays a
significant role in many important cardiovascular
disorders, and smooth muscle biology is therefore
important to cardiovascular research. The mouse is
critical to basic cardiovascular research, largely
because techniques for genetic manipulation are more
fully developed in the mouse than in any other
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mammalian species. We describe here a technique
for isolating smooth muscle cells from a single
mouse aorta. This technique is particularly useful
when material is limiting, as is frequently the
case when genetically modified animals are being
characterized.
II. Instruments
01. The following instruments were obtained from
Biomedical Research Instruments (BRI) Inc.5
– Small sharp scissors: BRI #28-1000.
– Toothed forceps: BRI #10-2440.
– Straight fine forceps: BRI #10-3150.
– Angled fine forceps: BRI #10-3110.
– Microdissecting scissors: BRI #11-1390.
02. A dissecting microscope is also necessary. We
used a TMS microscope from Nikon.9
III.  General supplies
– Small tissue culture tubes: Falcon 35-2054,
Becton Dickinson.6
– 15 ml conical polypropylene tubes: Falcon
352097, Becton Dickinson.6
– 48-well plates: Corning Costar 3548, VWR
Scientific Products.7
– 100 mm Petri dishes: Falcon 353003, Becton
Dickinson.6
– 3 ml syringes; Falcon 309585, Becton
Dickinson.6
– 1 ml syringes: BD 309602, Becton Dickinson.6
– 26 12 gauge needles: BD 305111, Becton
Dickinson.6
3.  Procedures
01. Euthanize mouse by using a 1 ml syringe
fitted with a 26 12 gauge needle to administer an
intraperitoneal injection of 0.25 ml of sodium
pentobarbital.
02. Place mouse in supine position on a small
styrofoam board. Immobilize by pinning each
paw to the styrofoam. Place under a dissecting
microscope.
03. Rinse off thorax and abdomen with a 70%
ethanol/30% water solution.
04. Incise and remove skin from thorax and abdomen
with small sharp sterile scissors and toothed
forceps. After skin is removed, dip instruments
in 70% ethanol/30% water, then in DMEM.
05. Open thorax to expose heart and lungs. Set
scissors and toothed forceps aside and use sterile
straight fine forceps and sterile angled fine
forceps for the remainder of the dissection.
06. Dissect out the aorta from its origin at the left
ventricle to the iliac bifurcation. Leave the aorta
attached to the left ventricle.
07. Use a 3 ml syringe fitted with a 26 1/2 gauge to
puncture the left ventricle. Perfuse with 3 ml
sterile phosphate buffered saline, so that the aorta
is flushed.
08. Remove the aorta, using sterile microdissecting
scissors, and place in a 100 mm Petri dish, in a
drop or two of Fungizone solution.
09. Dispose of the mouse carcass.
10. Using the straight and angled forceps (the angled
forceps to hold down the aorta and the straight
forceps to pull off bits of tissue), and working
under dissecting microscope, remove adventitia
from aorta. The adventitia will appear as ragged
bits of tissue coming off the aorta. When it is
removed, the aorta will be a smooth tube.
11. Remove aorta from Fungizone and place in a new
100 mm Petri dish, in one or two drops of culture
medium.
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Figure 1.  Less than 1% of isolated cells are recognized by an antibody directed against the endothelial cell-specific
CD31 antigen. Cultured smooth muscle cells were incubated with an anti-CD31 antibody and then with a fluorescein-
conjugated secondary antibody. In negative controls using NIH 3T3 fibroblasts (A), or smooth muscle cell preparations
in which primary antibody is omitted (B), there is no significant fluorescence (0.06% of cell stain in B). When smooth
muscle cell preparations were stained with primary and secondary antibodies, 0.73% of cells stain (C). In each graph,
the abscissa is a log scale of fluorescence and the ordinate is cell number. 10,000 live cells were counted to produce
each graph.
12. Cut the aorta into pieces that are approximately
square and 1–2 mm on a side, using microdis-
secting scissors or a scalpel. Cover Petri dish and
move to a tissue culture hood. 
13. Working in hood, place pieces of aorta into a
small tissue culture tube containing 100 µl of
enzyme solution.
14. Tape tube cap awry so that it still covers tube but
allows free exchange of incubator air.
15. Place in standard tissue culture incubator at
37 °C, 5% CO2, for four to six hours.
16. Remove tube from incubator and flick gently to
resuspend cells.
17. Add 3 ml culture medium.
18. Transfer to 15 ml conical polypropylene tube and
centrifuge for 5 minutes, 300 ×g at room tem-
perature in tabletop centrifuge.
19. Aspirate off medium and resuspend cells in 5 ml
fresh medium.
20. Centrifuge as before.
21. Resuspend cells in 700 µl medium and transfer
to a single well of a 48-well plate.
22. Place in incubator as before and leave undis-
turbed for 5 days.
General Notes:
Fully grown mice (e.g. at least eight weeks old)
provide significantly more smooth muscle cells than
young mice (e.g. 3 weeks old).
In our hands, substitution with other types of col-
lagenase yielded inferior results.
There is a risk of contamination, particularly
fungal contamination, if steps are not taken to prevent
it. Instruments should be sterilized in an autoclave
in preparation for the procedure, and the scissors and
forceps used to remove skin should be set aside and
not used again, as noted in the Basic Protocol section
above. It is also advisable to occasionally dip the
instruments into 70% ethanol/30% water, then into
sterile DMEM, as one performs the dissection. If
these steps are incorporated into the protocol conta-
mination should not occur.
Digestion time courses were performed as part of
developing this protocol. Every two hours following
the initiation of digestion, the sample was agitated,
a 2 µl aliquot was taken, and the number of free cells
in the aliquot was counted on a hemacytometer.
Enzymatic digestion times of four to six hours are
optimal. Shorter and longer times result in the isola-
tion of smaller numbers of cells. Cells isolated after
four to six hours of digestion are essentially all
smooth muscle cells (see Results and Discussion).
Cells isolated after shorter and longer periods of
digestion were less rigorously analyzed, but based on
morphological criteria these preparations seem to
also consist exclusively, or nearly exclusively, of
smooth muscle cells.
4.  Results and discussion
A number of lines of evidence lead to the conclu-
sion that the cell populations isolated by this proce-
dure are almost pure smooth muscle cells. The most
likely non-smooth muscle cell type to be isolated
using this protocol is the endothelial cell [2]. Flow
cytometry studies using antibodies directed against
CD31, an endothelial-specific surface antigen,
showed that less than 1% of cells reacted to that
antibody, indicating that no more than 1% of cells
in these cultures were endothelial cells (Figure 1).
In addition, when these cell cultures were stained
with antibodies directed against smooth muscle-
specific proteins (smooth muscle alpha-actin and
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Figure 2.  Fluorescent smooth muscle cells from a trans-
genic mouse. Aortic smooth muscle cells were cultured
as described, then fixed and stained with primary antibody
directed against smooth muscle alpha-actin and secondary
antibody conjugated to Texas red. (A) Visualization under
appropriate filters on a fluorescence microscope shows the
fibrillar pattern typical of smooth muscle alpha-actin.
(B) When the filters are changed to allow visualization
of yellow fluorescent protein, expression is observed in
a subset of smooth muscle cells. (See Results and
Discussion for fuller description of the background of this
experiment.)
calponin), no nonstaining cells were observed (Figure
2 and data not shown). We therefore regard 99% as
a conservative estimate of the purity of the smooth
muscle cell population.
The cells from a single aorta were near-confluent
(at least 6000 cells/well of a 48-well plate) after 7–10
days. This result was entirely reproducible in many
independent cell isolation procedures. At this point
certain types of characterization of the cell popula-
tion (immunological, morphological, growth rate,
migration) may be performed. Studies that require
larger numbers of cells require longer periods of
culture. For example, for flow cytometry, in which
10,000 cells were used in an experiment, culture
periods of 12–14 days were typically necessary to
analyze cells from a single aorta.
Figure 2 shows an example of this technique’s
utility. Transgenic mice were made with the yellow
fluorescent protein under the control of a smooth
muscle-specific promoter, that of the SM22-alpha
gene. PCR data showed that the transgene had
integrated in seven founder mice. Examination of
the founder mice (by examining clipped ears and
tails under a fluorescence microscope) provided no
evidence of fluorescence. Examination of aortic and
femoral artery sections from transgenic F1 mice also
showed no fluorescence above background when
compared to controls. Aortic smooth muscle cells
were then prepared by the technique describe here,
and expression of the transgene was easily detected
in a subset of smooth muscle cells from one of the
seven founder lines, as shown in Figure 2. The ability
to use a single mouse in this assay allowed rapid
detection of the most useful line, and limited the time
during which it was necessary to maintain and prop-
agate less useful lines.
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